SCHEDULE: GoldenTree Boosts Bausch Health Stake to 9.5%
Beneficial Ownership Disclosure
GoldenTree Asset Management and Steven A. Tananbaum have disclosed a combined beneficial ownership of 9.5% in Bausch Health Companies Inc. common shares.
Summary
- GoldenTree Asset Management LP and GoldenTree Asset Management LLC collectively hold beneficial ownership of 34,254,889 common shares of Bausch Health Companies Inc., representing 9.3% of the class.
- Steven A. Tananbaum, managing member of GoldenTree Asset Management LLC, beneficially owns an aggregate of 35,243,712 common shares, equating to 9.5% of the class.
- Mr. Tananbaum's ownership includes 988,823 shares held directly and 34,254,889 shares shared with GoldenTree Asset Management LP and GoldenTree Asset Management LLC.
- The beneficial ownership is based on 369,550,086 common shares outstanding as of April 25, 2025, as reported in Bausch Health's Form 10-Q filed on May 1, 2025.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to previously reported ownership.
- The securities were not acquired and are not held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The filing is a standard beneficial ownership disclosure (Schedule 13G Amendment), which is neutral in sentiment. It provides factual information about ownership percentages without commentary on company performance or future prospects.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by GoldenTree Asset Management, a prominent investment firm, in Bausch Health Companies Inc. Such a substantial stake by an institutional investor can signal confidence in the company's long-term prospects or a strategic position within the healthcare sector, particularly in pharmaceuticals and eye health.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a major investment firm like GoldenTree Asset Management could be viewed positively, potentially signaling institutional confidence or a long-term investment horizon. It may also indicate a potential for future engagement, although the filing states the purpose is not to change or influence control.
Key Dates
| Date | Description |
|---|---|
| 2025-04-25 | Date as of which 369,550,086 Common Shares were outstanding, per Issuer's Form 10-Q. |
| 2025-05-01 | Date Bausch Health Companies Inc. filed its Quarterly Report on Form 10-Q. |
| 2025-06-30 | Date of event which requires filing of this statement. |
| 2025-08-14 | Signature date of the Schedule 13G Amendment No. 2. |
Keywords
Bausch Health Companies Inc., GoldenTree Asset Management, Steven A. Tananbaum, Beneficial Ownership, Schedule 13G, Common Shares, Institutional Investor, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.